{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:40Z","timestamp":1762508740318,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-022-06126-x","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T08:02:33Z","timestamp":1647417753000},"page":"1597-1601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7893-815X","authenticated-orcid":false,"given":"Chantal","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Krampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Doerfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Morgenlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"6126_CR1","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, and C4591001 Clinical Trial Group (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603\u20132615","DOI":"10.1056\/NEJMoa2034577"},{"issue":"5","key":"6126_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","volume":"68","author":"D Kanduc","year":"2020","unstructured":"Kanduc D, Shoenfeld Y (2020) Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res 68(5):310\u2013313","journal-title":"Immunol Res"},{"key":"6126_CR3","doi-asserted-by":"crossref","unstructured":"A. Dotan, S. Muller, D. Kanduc, P. David, G. Halpert, and Y. Shoenfeld (2021) \u201cThe SARS-CoV-2 as an instrumental trigger of autoimmunity.,\u201d Autoimmun. Rev., vol. 20, no. 4, p. 102792.","DOI":"10.1016\/j.autrev.2021.102792"},{"key":"6126_CR4","unstructured":"Justiz Vaillant AA, Goyal A, Bansal P, Varacallo M (2021) Systemic Lupus Erythematosus. in StatPearls. StatPearls Publishing, Treasure Island"},{"issue":"1","key":"6126_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","volume":"80","author":"A Fanouriakis","year":"2021","unstructured":"Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update \u03bfn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80(1):14\u201325","journal-title":"Ann Rheum Dis"},{"issue":"50","key":"6126_CR6","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","volume":"69","author":"SE Oliver","year":"2020","unstructured":"Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K (2020) The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep 69(50):1922\u20131924","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6126_CR7","unstructured":"\u201cVaccines and Related Biological Products Advisory Committee Meeting.\u201d https:\/\/www.fda.gov\/media\/144434\/download. Accessed May, 2021"},{"key":"6126_CR8","doi-asserted-by":"publisher","first-page":"e931478","DOI":"10.12659\/AJCR.931478","volume":"22","author":"ER King","year":"2021","unstructured":"King ER, Towner E (2021) A case of immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination. Am. J. Case Rep 22:e931478","journal-title":"Am. J. Case Rep"},{"issue":"6","key":"6126_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/jth.15291","volume":"19","author":"M Radwi","year":"2021","unstructured":"Radwi M, Farsi S (2021) A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost 19(6):1515\u20131518","journal-title":"J Thromb Haemost"},{"key":"6126_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijid.2021.07.035","volume":"110","author":"G Renisi","year":"2021","unstructured":"Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A (2021) Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis 110:95\u201397","journal-title":"Int J Infect Dis"},{"key":"6126_CR11","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.bbih.2021.100217","volume":"13","author":"M Repajic","year":"2021","unstructured":"Repajic M, Lai XL, Xu P, Liu A (2021) Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy. Brain Behav Immun Health 13:100217","journal-title":"Brain Behav Immun Health"},{"key":"6126_CR12","doi-asserted-by":"crossref","unstructured":"Kreuter A, Licciardi-Fernandez MJ, Burmann SN, Burkert B, Oellig F, Michalowitz AL (2021) Induction and exacerbation of subacute cutaneous lupus erythematosus following messenger-RNA or adenoviral-vector based SARS-CoV-2 vaccination. Clin Exp Dermatol 47(1):161\u2013163","DOI":"10.1111\/ced.14858"},{"key":"6126_CR13","doi-asserted-by":"crossref","unstructured":"Kreuter A, Burmann SN, Burkert B, Oellig F, Michalowitz AL (2021) Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination. J Eur Acad Dermatol Venereol 35(11):e733\u2013e735","DOI":"10.1111\/jdv.17514"},{"issue":"13","key":"6126_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/0961203309345732","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Zafrir Y, Paz Z, Shilton T, Zandman-Goddard G, Shoenfeld Y (2009) Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus 18(13):1192\u20131197","journal-title":"Lupus"},{"issue":"1","key":"6126_CR15","doi-asserted-by":"publisher","first-page":"170.e3","DOI":"10.1016\/j.ajem.2017.10.020","volume":"36","author":"AD Holmes","year":"2018","unstructured":"Holmes AD, Abbasi OZ, Jacoby JL (2018) Systemic lupus erythematosus following meningococcal vaccination. Am J Emerg Med 36(1):170.e3-170.e4","journal-title":"Am J Emerg Med"},{"key":"6126_CR16","doi-asserted-by":"crossref","unstructured":"Mason A, Anver H, Lwin M, Holroyd C, Faust SN, Edwards CJ (2021) Lupus, vaccinations and COVID-19: what we know now. Lupus 9612033211024356","DOI":"10.1177\/09612033211024355"},{"key":"6126_CR17","doi-asserted-by":"publisher","first-page":"108665","DOI":"10.1016\/j.clim.2021.108665","volume":"224","author":"R Talotta","year":"2021","unstructured":"Talotta R (2021) \u201cDo COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u2018potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 224:108665","journal-title":"Clin Immunol"},{"issue":"5663","key":"6126_CR18","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663):1526\u20131529","journal-title":"Science"},{"issue":"7","key":"6126_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1080\/15548627.2015.1052206","volume":"11","author":"CG Weindel","year":"2015","unstructured":"Weindel CG, Richey LJ, Bolland S, Mehta AJ, Kearney JF, Huber BT (2015) B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy 11(7):1010\u20131024","journal-title":"Autophagy"},{"issue":"3","key":"6126_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, Terada Y, Sano S (2014) Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol 66(3):694\u2013706","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"6126_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21(4):195\u2013197","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"6126_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","volume":"25","author":"J Banchereau","year":"2006","unstructured":"Banchereau J, Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3):383\u2013392","journal-title":"Immunity"},{"key":"6126_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","volume":"67","author":"M Postal","year":"2020","unstructured":"Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB (2020) Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol 67:87\u201394","journal-title":"Curr Opin Immunol"},{"key":"6126_CR24","doi-asserted-by":"crossref","unstructured":"Gadotti AC, de Castro Deus M, Telles JP, Wind R, Goes M, Garcia Charello Ossoski R, de Padua AM, de Noronha L, Moreno-Amaral A, Baena CP, Tuon FF (2020) IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res 289: 198171","DOI":"10.1016\/j.virusres.2020.198171"},{"issue":"7","key":"6126_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/jir.2018.0169","volume":"39","author":"Y Tang","year":"2019","unstructured":"Tang Y, Tao H, Gong Y, Chen F, Li C, Yang X (2019) Changes of Serum IL-6, IL-17, and complements in systemic lupus erythematosus patients. J Interferon Cytokine Res 39(7):410\u2013415","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"6126_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.autrev.2007.11.014","volume":"7","author":"J Rovensk\u00fd","year":"2008","unstructured":"Rovensk\u00fd J, Tuchynov\u00e1 A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7(3):235\u2013239","journal-title":"Autoimmun Rev"},{"issue":"9","key":"6126_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2165\/00002512-200724090-00001","volume":"24","author":"D Lazaro","year":"2007","unstructured":"Lazaro D (2007) Elderly-onset systemic lupus erythematosus. Drugs Aging 24(9):701\u2013715","journal-title":"Drugs Aging"},{"key":"6126_CR28","unstructured":"Department of health Pennsylvania. https:\/\/www.health.pa.gov\/topics\/disease\/coronavirus\/Vaccine\/Pages\/Dashboard.aspx. Accessed February, 2022"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06126-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:07:36Z","timestamp":1651316856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6126"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06126-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report has not been submitted elsewhere and is not under consideration by another journal. The case report information will not be submitted or published elsewhere while it is under review by this journal unless rejected by journal or withdrawn by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Other disclosure"}},{"value":"Dr. Aggarwal has received research grant and consulting fee from Pfizer. The other authors have disclosed no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}